With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.78551-60-7,tert-Butyl 4-benzyl-3-oxopiperazine-1-carboxylate,as a common compound, the synthetic route is as follows.,78551-60-7
To a solution of oxalyl chloride (214 mg, 1.65 mmol) in CH2CI2 (2.5 ml) in a dryice-acetone bath was added DMSO (356 mg, 4.56 mmol). After 5 min, a solution ofthe product of Step 7 (508 mg, 1.41 mmol) in CH2CI2 (3.5 ml) was added and themixture was stirred for 1 h. Triethylamine (700 nl, 5.02 mmol) was added and themixture was stirred for 15 min. The mixture was warmed to RT and stirred for 15 min.Water (30 ml) and CH2CI2 (40 ml) were added and the aqueous layer was extractedwith CH2CI2 (30 ml). The combined organic layer was washed with brine (50 ml),dried (MgSO/O, and concentrated to give the aldehyde, which was not further purified.To a solution of diisopropylamine (188 mg, 1.86 mmol) in THF (2.5 ml) in a dryice-acetone bath was added 1.6 M butyllithium in hexanes (1.40 ml, 2.24 mmol).After 5 min the mixture was put in an ice-water bath and stirred for 20 min. Thesolution was cooled in the dry ice-acetone bath again and a solution of the product ofPreparative Example 1, Step 5 (460 mg, 1.59 mmol) in THF (4 ml) was added. Themixture was stirred for 1 h. A solution of the above aldehyde in THF (4 ml) wasadded and the mixture was stirred for 1.5 h. The reaction was quenched with water(40 ml) and extracted with ether (50 ml). The aqueous layer was extracted with ether(3×40 ml). The combined organic layer was washed with brine (50 ml), dried(MgSO4), concentrated, and purified by PTLC (40% EtOAc/Hexanes) to give: fraction1 (137 mg, 15%). MS m/e 648 (M+H)+; fraction 2 (148 mg, 16%). MS m/e 648 (M+H)+
78551-60-7 tert-Butyl 4-benzyl-3-oxopiperazine-1-carboxylate 10891590, apiperazines compound, is more and more widely used in various fields.
Reference:
Patent; SCHERING CORPORATION; WO2006/14762; (2006); A1;,
Piperazine – Wikipedia
Piperazines – an overview | ScienceDirect Topics